Status: Recruiting
A Study to Investigate the Safety, Reactogenicity, and Immunogenicity of mRNA-1469 Vaccine to Prevent Ebola-Bundibugyo Virus Disease in Healthy Adult Participants
The main objective of this trial is to evaluate the safety and reactogenicity of mRNA-1469
Participants needed: 84
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: ModernaTX, Inc.Updated: Aug 11, 2026Locations: 3
Eligibility criteria
In good general health or with stable chronic medical conditions, as determined... [+2]
History of anaphylaxis or severe hypersensitivity reaction requiring medical int... [+6]